On Monday, October 6, Technology Transfer and Business Development (TTBD) hosted the 2014 TTBD Awards to recognize OHSU researchers who had technologies licensed or optioned in the last fiscal year as well as those who brought in top dollars from industry to support their research. The ceremony drew an enthusiastic crowd to the Portland State University lecture hall at the new Collaborative Life Sciences Building.
We’d like to congratulate all of the researchers who were recognized at this year’s Innovation Awards ceremony, including:
Technology Transfer Achievement Award: Arthur Vandenbark, PhD
Dr. Vandenbark is a Professor of MMI and Neurology at OHSU and a Senior Research Career Scientist at the VAMC. He is the Co-Director of the Neuroimmunology Program that is focused on the development and translation of novel therapeutic immunoregulatory and neuroprotective agents for treatment of multiple sclerosis and other autoimmune and inflammatory diseases of the central nervous system. Since 1999, Dr. Vandenbark has disclosed 27 new inventions to Technology Transfer, 11 of which are exclusively licensed. He is also an inventor on 15 issued US patents and has collaborated with industry on several research studies.
New Inventor of the Year Award: Michael P. Hutchens, M.D., M.A.
Dr. Hutchens serves as Associate Professor in the Department of Anesthesiology & Perioperative Medicine and is a critical care physician in the Knight Cardiovascular Intensive Care Unit. Dr. Hutchens is the recipient of a NIDDK-funded K08 grant for his research focusing on sex and acute kidney injury. Dr. Hutchens is also the recipient of an OHSU Biomedical Innovation Program Award. OHSU has filed patents on two of Dr. Hutchens’ nine disclosed inventions, one of which is exclusively optioned to a company for evaluation. Dr. Hutchens’ inventions thus far focus on bringing smart, reliable technology to the patient as wearable or bedside devices to improve safety.
Business Partnership Achievement Award: Sanjiv Kaul, M.D.
Dr. Kaul is currently the Ernest C. Swigert Chair of Cardiovascular Medicine, Professor of Medicine and Radiology, CEO of the Knight Cardiovascular Institute and Associate Dean, School of Medicine at OHSU. His major clinical and research interest is coronary artery disease. He is a pioneer in cardiovascular imaging, having spearheaded many of the developments in contrast echocardiography and making major contributions to the field of nuclear cardiology.
TTBD also recognized the hard work of the OHSU Office of Proposal and Award Management with an award of appreciation.